176 related articles for article (PubMed ID: 20172001)
1. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2.
Zhang H; Feng H; Luo L; Zhou Q; Luo Z; Peng Y
Virus Res; 2010 Jun; 150(1-2):22-7. PubMed ID: 20172001
[TBL] [Abstract][Full Text] [Related]
2. MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71).
Wang B; Zhang H; Zhu M; Luo Z; Peng Y
Antiviral Res; 2012 Jan; 93(1):110-7. PubMed ID: 22101247
[TBL] [Abstract][Full Text] [Related]
3. Suppression of coronavirus replication by inhibition of the MEK signaling pathway.
Cai Y; Liu Y; Zhang X
J Virol; 2007 Jan; 81(2):446-56. PubMed ID: 17079328
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
6. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
7. MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression.
Huth HW; Albarnaz JD; Torres AA; Bonjardim CA; Ropert C
Cell Signal; 2016 Sep; 28(9):1283-1291. PubMed ID: 27181679
[TBL] [Abstract][Full Text] [Related]
8. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
[TBL] [Abstract][Full Text] [Related]
9. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway.
Wang C; Wang P; Chen X; Wang W; Jin Y
Antiviral Res; 2015 Jul; 119():47-56. PubMed ID: 25912818
[TBL] [Abstract][Full Text] [Related]
10. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.
Ohren JF; Chen H; Pavlovsky A; Whitehead C; Zhang E; Kuffa P; Yan C; McConnell P; Spessard C; Banotai C; Mueller WT; Delaney A; Omer C; Sebolt-Leopold J; Dudley DT; Leung IK; Flamme C; Warmus J; Kaufman M; Barrett S; Tecle H; Hasemann CA
Nat Struct Mol Biol; 2004 Dec; 11(12):1192-7. PubMed ID: 15543157
[TBL] [Abstract][Full Text] [Related]
11. Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
Voisin L; Julien C; Duhamel S; Gopalbhai K; Claveau I; Saba-El-Leil MK; Rodrigue-Gervais IG; Gaboury L; Lamarre D; Basik M; Meloche S
BMC Cancer; 2008 Nov; 8():337. PubMed ID: 19014680
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of MEK inhibitors on rat neural stem cell differentiation: Repressive roles of MEK2 in neurogenesis and induction of astrocytogenesis by PD98059.
Lee HR; Lee J; Kim HJ
Pharmacol Res; 2019 Nov; 149():104466. PubMed ID: 31562895
[TBL] [Abstract][Full Text] [Related]
13. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.
Yeh JJ; Routh ED; Rubinas T; Peacock J; Martin TD; Shen XJ; Sandler RS; Kim HJ; Keku TO; Der CJ
Mol Cancer Ther; 2009 Apr; 8(4):834-43. PubMed ID: 19372556
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
15. MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells.
Zhou L; Tan X; Kamohara H; Wang W; Wang B; Liu J; Egami H; Baba H; Dai X
Oncol Rep; 2010 Jul; 24(1):251-5. PubMed ID: 20514469
[TBL] [Abstract][Full Text] [Related]
16. Tight control of MEK-ERK activation is essential in regulating proliferation, survival, and cytokine production of CD34+-derived neutrophil progenitors.
Geest CR; Buitenhuis M; Groot Koerkamp MJ; Holstege FC; Vellenga E; Coffer PJ
Blood; 2009 Oct; 114(16):3402-12. PubMed ID: 19667405
[TBL] [Abstract][Full Text] [Related]
17. Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway.
Zaheer RS; Koetzler R; Holden NS; Wiehler S; Proud D
J Immunol; 2009 Apr; 182(8):4854-64. PubMed ID: 19342664
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.
Xu S; Khoo S; Dang A; Witt S; Do V; Zhen E; Schaefer EM; Cobb MH
Mol Endocrinol; 1997 Oct; 11(11):1618-25. PubMed ID: 9328344
[TBL] [Abstract][Full Text] [Related]
19. The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility.
Yamashita S; Tai P; Charron J; Ko C; Ascoli M
Mol Endocrinol; 2011 Jul; 25(7):1211-22. PubMed ID: 21527500
[TBL] [Abstract][Full Text] [Related]
20. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.
Caunt CJ; Sale MJ; Smith PD; Cook SJ
Nat Rev Cancer; 2015 Oct; 15(10):577-92. PubMed ID: 26399658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
